New York, NY – August 10, 2018 – Welsh, Carson, Anderson & Stowe (the “Firm” or “WCAS”), a private equity firm exclusively focused on technology and healthcare, completed an investment in Asurion (the “Company”) as part of an equity recapitalization.
To read more about this post, click here to access the full content.
New York, New York, November 21, 2024 – Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm specializing in the technology and healthcare industries, is pleased to announce
New York, New York, November 18th, 2024 – Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused on the healthcare and technology industries, announced today that Ann
New York, NY – November 14, 2024 -- Welsh, Carson, Anderson & Stowe (“WCAS” or the “Firm”), a leading private equity firm focused exclusively on the technology and healthcare industries,
New York, October 23, 2024 – EquiLend, the global leader in technology, data, and analytics solutions for the securities finance industry, today announced the appointment of Rich Grossi as its new
New York, NY – September 19, 2024 -- Welsh, Carson, Anderson & Stowe (“WCAS” or the “Firm”), a leading private equity firm focused exclusively on the technology and healthcare industries, announced
Private equity backing to accelerate growth initiatives for EquiLend New York, September 5, 2024 – EquiLend, the global technology, data and analytics company for the securities finance industry, today announces the
